Prior to founding Speratum, Dr. Marín Müller earned his Ph.D. in Molecular Virology and Microbiology from Baylor College of Medicine, where he made significant contributions to cancer research and innovative therapeutic approaches. He also holds an MSc in Entrepreneurship from Case Western Reserve University and a BS in Molecular Biology from Florida Tech.

Dr. Marín Müller’s extensive academic and professional journey has positioned him at the forefront of oncological biotechnology, where he has led numerous groundbreaking research projects. With a deep commitment to eradicating cancer, he co-invented Speratum’s advanced platforms, drawing on decades of scientific insight and cutting-edge technology. Throughout his career, Dr. Marín Müller has authored influential peer-reviewed publications and has been recognized for his leadership in the field, combining his scientific expertise with a passion for innovation to drive Speratum’s mission forward.